Pituitary-adrenal axis suppression due to topical steroid administration in an infant

Pediatrics International

Volumn 49, Issue 2, 2007, Pages 242-244

  Atabek, Mehmet Emre ^a   Pirgon, Ozgur ^a   Unal, Ekrem ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Adrenal suppression; Corticosteroid; Cushing syndrome; Iatrogenic

Indexed keywords

CLOBETASOL PROPIONATE; STEROID;

ANAMNESIS; ARTICLE; BLOOD PRESSURE; BODY MASS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INFANT; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN; THYROID FUNCTION;

ADMINISTRATION, TOPICAL; CLOBETASOL; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; HUMANS; IATROGENIC DISEASE; INFANT;

EID: 34147102909     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02330.x     Document Type: Article

References (10)

1. Prawer SE, Katz HI. Guidelines for using superpotent topical steroids. Am. Fam. Physician 1990; 41: 1531-8.
2. Feiwel M. Percutaneous absorption of topical steroids in children. Br. J. Dermatol. 1969; 81 (Suppl. 4): 113-16.
3. Turpeinen M, Salo O, Leisti S. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br. J. Dermatol. 1986; 115: 475-84.
4. Ohman EM, Rogers S, Meenan FO et al. Adrenal suppression following low dose clobetasol propionate. J. R. Soc. Med. 1987; 80: 422-3.
5. Murray JR. Regulatory affairs: Corticosteroids and the skin. J. Dermatol. Treat. 1994; 5: 121.
6. Clement M, du Vivier A. Topical Steroids for Skin Disorders. Blackwell, Boston, 1987.
7. Fritz KA, Weston L. Topical corticosteroids. Ann. Allergy 1983; 50: 6800-870.
8. Daman Willems CE, Dinwiddie R, Grant DB, Rivers RP, Zahir M. Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops. Eur. J. Pediatr. 1994; 153: 632-4.
9. Hepburn D, Yohn JJ, Weston WL. Topical steroid treatment in infants, children and adolescents. Adv. Dermatol. 1994; 9: 225-55.
10. Malozowski S, Purucker M, Worobec A. Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation. BMJ 1999; 318: 1355.